Menu
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Everywhere
Threads
This forum
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Info Obat dan Regulator Obat Dunia
Prev
1
…
Go to page
Go
24
25
26
27
28
…
Go to page
Go
126
Next
First
Prev
26 of 126
Go to page
Go
Next
Last
Filters
Show only:
Loading…
C
Xephyr, LLC dba N-Ergetics - 604588 - 03/06/2020
Center for Drug Evaluation and Research
Jun 15, 2023
Replies
0
Views
287
Jun 15, 2023
Center for Drug Evaluation and Research
C
F
FDA approves first treatment for pediatric functional constipation
FDA
Jun 13, 2023
Replies
0
Views
235
Jun 13, 2023
FDA
F
F
Letter of Support (LOS) Initiative
FDA
Jun 13, 2023
Replies
0
Views
281
Jun 13, 2023
FDA
F
F
Untitled Letters 2019
FDA
Jun 13, 2023
Replies
0
Views
305
Jun 13, 2023
FDA
F
F
Untitled Letters 2020
FDA
Jun 13, 2023
Replies
0
Views
330
Jun 13, 2023
FDA
F
F
Untitled Letters 2023
FDA
Jun 13, 2023
Replies
0
Views
272
Jun 13, 2023
FDA
F
F
Fresenius Kabi Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP Due to the Presence of Particulate Matter
FDA
Jun 13, 2023
Replies
0
Views
233
Jun 13, 2023
FDA
F
F
Warning Letters and Notice of Violation Letters to Pharmaceutical Companies
FDA
Jun 13, 2023
Replies
0
Views
208
Jun 13, 2023
FDA
F
F
Untitled Letters 2018
FDA
Jun 13, 2023
Replies
0
Views
304
Jun 13, 2023
FDA
F
E
EMA Management Board: highlights of June 2023 meeting, MB, 09/06/2023
EMA
Jun 10, 2023
Replies
0
Views
259
Jun 10, 2023
EMA
E
E
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5 - 8 June 2023, PRAC, 09/06/2023
EMA
Jun 10, 2023
Replies
0
Views
294
Jun 10, 2023
EMA
E
F
Assessing User Fees Under the Generic Drug User Fee Amendments of 2022
FDA
Jun 10, 2023
Replies
0
Views
187
Jun 10, 2023
FDA
F
F
Nalpropion Pharmaceuticals LLC - 09/22/2020
FDA
Jun 10, 2023
Replies
0
Views
301
Jun 10, 2023
FDA
F
F
FDA Roundup: June 9, 2023
FDA
Jun 10, 2023
Replies
0
Views
243
Jun 10, 2023
FDA
F
F
Nalpropion Pharmaceuticals LLC - 610942 - 05/10/2023
FDA
Jun 10, 2023
Replies
0
Views
294
Jun 10, 2023
FDA
F
O
Currax Pharmaceuticals LLC - 610942 - 09/22/2020
Office of Prescription Drug Promotion
Jun 10, 2023
Replies
0
Views
209
Jun 10, 2023
Office of Prescription Drug Promotion
O
F
Locate a State-Licensed Online Pharmacy
FDA
Jun 10, 2023
Replies
0
Views
289
Jun 10, 2023
FDA
F
F
Clinical Drug Interaction Studies With Combined Oral Contraceptives Guidance for Industry
FDA
Jun 10, 2023
Replies
0
Views
227
Jun 10, 2023
FDA
F
F
Content and Format of the RDEA Proposal | Rare Disease Endpoint Advancement Pilot Program
FDA
Jun 8, 2023
Replies
0
Views
196
Jun 8, 2023
FDA
F
F
Drug Trials Snapshot: CIBINQO
FDA
Jun 8, 2023
Replies
0
Views
254
Jun 8, 2023
FDA
F
Prev
1
…
Go to page
Go
24
25
26
27
28
…
Go to page
Go
126
Next
First
Prev
26 of 126
Go to page
Go
Next
Last
You must log in or register to post here.
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
Top